was not possible to perform a meta-analysis on combination markers. Therefore, we 54 proceeded to perform a meta-analysis on ultrasound markers alone to determine the best 55 marker that can help to improve the diagnostic accuracy of predicting miscarriage in women 56 with viable intrauterine pregnancy. The systematic review identified 18 eligible studies for 57 the quantitative meta-analysis with a total of 5584 women. Among the ultrasound scan 58 markers, fetal bradycardia (n=10 studies, n=1762 women) on hierarchical summary receiver 59 operating characteristic showed sensitivity of 68.41%, specificity of 97.84%, positive 60 likelihood ratio of 31.73 (indicating a large effect on increasing the probability of predicting 61
Introduction

82
Miscarriage complicates 2-20% of pregnancies after demonstration of fetal cardiac activity on 83 an ultrasound scan (1, 2). The incidence increases further with vaginal bleeding in early 84 pregnancy (1) . Pain and bleeding are associated with significant fear and anxiety about losing 85 the pregnancy. In the presence of markers with high diagnostic value for predicting 86 miscarriage, women can be counselled appropriately and follow up scans pre-empted. 87 Both ultrasound (USS) and biochemical markers either alone or in combination have been symptomatic and asymptomatic women with viable intrauterine pregnancies on scan (3, 4). 95 We sought to perform this systematic review and meta-analysis to determine the best 96 combination of biochemical, ultrasound and demographic markers to predict miscarriage in 97 women with viable intrauterine pregnancy. Initially the systematic review was planned to look 98 into studies that used markers in combination for prediction. However, following the initial 99 review it was evident that many combinations of markers have been tested with varying 100 diagnostic accuracy and it was not possible to perform a meta-analysis due to the diversity of 101 the combinations used. Ultrasound seemed to be the common marker in combination with 102 either demographic or biochemical markers. Therefore, we proceeded to perform a meta-103 analysis on ultrasound markers alone to determine the best marker that can help to improve 104 the diagnostic accuracy of predicting miscarriage in women with viable intrauterine 105 pregnancy.
106
Materials and Methods
107
A protocol of this review was registered in the PROSPERO International Prospective Register 108 of Systematic Reviews (CRD42016046470). Data extraction and quality assessment 138 Using predetermined forms, data were extracted independently by 2 authors (RNP and NP). 
Fetal bradycardia
233
There were ten studies that investigated fetal bradycardia in predicting miscarriage (18-27) 234 and included asymptomatic women and those with vaginal bleeding (N=1762) (Fig. 3a) . (Fig. 3b) (Fig. 4a) (Fig. 4b) . (Fig. 6a) (Fig. 6b) .
262
A subgroup analysis was performed on women with vaginal bleeding (three studies; N= 595) 263 (21, 23, 29) and asymptomatic women (two studies; N= 541) (20, 28) . No significant difference 264 in the sensitivity and specificity was noted between the two groups. The results of this meta-analysis showed that CRL has lower predictive value than FHR for 308 miscarriage (CRL sensitivity of 59.81% and specificity of 55.68%; FHR sensitivity of 68.41% and 309 specificity of 97.84%). This could be due to the fact that embryos that measure small at the 310 initial scan are due to incorrect dates or are pregnancies that are likely to have fetal growth 311 restriction later on (37).
312
Abnormal YS size and appearance have been reported to be useful markers for miscarriage 313 prediction before the demonstration of fetal viability (38), however in presence of established 314 viable intra uterine pregnancy, its usefulness is limited. Probably for this reason there was 315 obvious lack of reporting about yolk sac measurements in the included studies. 316 We recognize some of the limitations of this meta-analysis. We were unable to do a meta-317 analysis on combination markers (biochemical, ultrasound and demographic factors), which 318 would have been extremely valuable. However, there was wide variation in the combination 319 markers used by the studies to do a meta-analysis. Another limitation was that the included 320 studies used both TA and TV scan to measure ultrasound markers, which could contribute to 321 measurement bias. Although at the protocol stage of the review the plan was to perform a 322 sensitivity analysis based on the scanning approach, this was not possible because there were 323 not enough studies in the two groups. 
